MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$619.66
+0.19%Forward multiples
Based on analyst estimates
- P/E forward
- 32.91x
- P/E 2026E
- 35.31x
- P/E 2027E
- 32.13x
- P/E 2028E
- 28.92x
- P/S forward
- 5.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.63x
- PEG TTM
- 4.31x
- Price / book
- 39.86x
- Price / sales
- 6.22x
- Price / cash flow
- 22.98x
Enterprise value
- Enterprise value
- $16.9B
- EV / sales
- 6.09x
- EV / EBITDA
- 27.50x
- EV / EBIT
- 29.03x
- Market cap
- $17.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026